280 related articles for article (PubMed ID: 20175830)
1. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
Osada S; Kimura Y; Kawana S
J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
[TBL] [Abstract][Full Text] [Related]
2. Livedoid vasculopathy; favorable clinical response with low dose warfarin.
Nakamura S; Kishibe M; Nishi K; Hashimoto Y; Takeda K; Mizumoto T; Iizuka H
Eur J Dermatol; 2011; 21(6):1011-2. PubMed ID: 21914587
[No Abstract] [Full Text] [Related]
3. [Vasculitis and vasculopathy].
Marković A
Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
[TBL] [Abstract][Full Text] [Related]
4. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
[TBL] [Abstract][Full Text] [Related]
5. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
Davis MD; Wysokinski WE
J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
[TBL] [Abstract][Full Text] [Related]
6. Livedoid vasculopathy: review of pathogenesis, clinical presentation, diagnostic workup, and treatment.
Haunson GT; Judy DW; Prall NC; Miller RA
Cutis; 2012 Dec; 90(6):302-6. PubMed ID: 23409480
[TBL] [Abstract][Full Text] [Related]
7. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].
Goerge T
Hautarzt; 2011 Aug; 62(8):627-34; quiz 635. PubMed ID: 21786003
[TBL] [Abstract][Full Text] [Related]
8. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
[TBL] [Abstract][Full Text] [Related]
9. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
[TBL] [Abstract][Full Text] [Related]
10. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia.
Browning CE; Callen JP
Arch Dermatol; 2006 Jan; 142(1):75-8. PubMed ID: 16415390
[TBL] [Abstract][Full Text] [Related]
11. Livedoid vasculopathy and hypercoagulability in a patient with primary Sjögren's syndrome.
Cardoso R; Gonçalo M; Tellechea O; Maia R; Borges C; Silva JA; Figueiredo A
Int J Dermatol; 2007 Apr; 46(4):431-4. PubMed ID: 17442092
[TBL] [Abstract][Full Text] [Related]
12. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
Kerk N; Goerge T
J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
[TBL] [Abstract][Full Text] [Related]
13. Livedoid vasculopathy - a thrombotic disease.
Kerk N; Goerge T
Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
Anavekar NS; Kelly R
Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of new low-dose oral anticoagulants in recalcitrant livedoid vasculopathy.
Furukawa F; Mizawa M; Makino T; Shimizu T
BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28739563
[TBL] [Abstract][Full Text] [Related]
16. Case of livedoid vasculopathy with extensive dermal capillary thrombi.
Shimizu A; Tamura A; Yamanaka M; Amano H; Nagai Y; Ishikawa O
J Dermatol; 2010 Jan; 37(1):94-7. PubMed ID: 20175829
[TBL] [Abstract][Full Text] [Related]
17. Livedoid vasculopathy secondary to high levels of lipoprotein(a).
Vasconcelos R; Criado PR; Belda W
Br J Dermatol; 2011 May; 164(5):1111-3. PubMed ID: 21219292
[No Abstract] [Full Text] [Related]
18. Livedoid vasculopathy: an intringuing cutaneous disease.
Criado PR; Rivitti EA; Sotto MN; Valente NY; Aoki V; Carvalho JF; Vasconcellos C
An Bras Dermatol; 2011; 86(5):961-77. PubMed ID: 22147037
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of Peripheral Neuropathy in Patients With Livedoid Vasculopathy.
Eswaran H; Traub R; Googe P; Moll S
J Clin Neuromuscul Dis; 2023 Mar; 24(3):157-161. PubMed ID: 36809203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
